B-CELL APLASIA

B-CELL APLASIA was reported 258 times

B-CELL APLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 46 0.0045
1 Interleukin-6 Antagonist [EPC] 1 0.0015
2 CD22-directed Immunoconjugate [EPC] 4 0.0013
3 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
4 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 6 0.0005
5 Lipid Emulsion [EPC] 1 0.0004
6 Human Immunoglobulin G [EPC] 7 0.0003
7 Plasma Volume Expander [EPC] 1 0.0003
8 Calcitonin [EPC] 1 0.0003
9 Interleukin-1 Receptor Antagonist [EPC] 5 0.0003
10 Alkylating Drug [EPC] 72 0.0003
11 Echinocandin Antifungal [EPC] 2 0.0002
12 Nuclear Export Inhibitor [EPC] 2 0.0002
13 alpha-1 Adrenergic Agonist [EPC] 1 0.0002
14 Gadolinium-based Contrast Agent [EPC] 1 0.0002
15 CD20-directed Cytolytic Antibody [EPC] 61 0.0002
16 Lipid-based Polyene Antifungal [EPC] 2 0.0002
17 Topoisomerase Inhibitor [EPC] 11 0.0001
18 Calcineurin Inhibitor Immunosuppressant [EPC] 17 0.0001
19 Anticholinergic [EPC] 2 0.0001
20 Vitamin K [EPC] 1 0.0001
21 Interleukin-6 Receptor Antagonist [EPC] 16 0.0001
22 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
23 Antimalarial [EPC] 1 0.0001
24 Antiprotozoal [EPC] 1 0.0001
25 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0001
26 Proteasome Inhibitor [EPC] 10 0.0001
27 Barbiturate [EPC] 1 0.0001
28 BCL-2 Inhibitor [EPC] 5 0.0001
29 Nucleoside Metabolic Inhibitor [EPC] 14 0.0001
30 Polyene Antifungal [EPC] 2 0.0000
31 Platinum-based Drug [EPC] 13 0.0000
32 Antimetabolite Immunosuppressant [EPC] 1 0.0000
33 Glycopeptide Antibacterial [EPC] 3 0.0000
34 Leukocyte Growth Factor [EPC] 6 0.0000
35 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 4 0.0000
36 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
37 Corticosteroid [EPC] 52 0.0000
38 Radiographic Contrast Agent [EPC] 1 0.0000
39 Azole Antifungal [EPC] 6 0.0000
40 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
41 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
42 Kinase Inhibitor [EPC] 18 0.0000
43 Folate Analog Metabolic Inhibitor [EPC] 13 0.0000
44 Thalidomide Analog [EPC] 13 0.0000
45 Catecholamine [EPC] 2 0.0000
46 Nucleoside Analog Antiviral [EPC] 2 0.0000
47 Insulin [EPC] 1 0.0000
48 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
49 Purine Antimetabolite [EPC] 2 0.0000
50 Ester Local Anesthetic [EPC] 1 0.0000
51 Antirheumatic Agent [EPC] 2 0.0000
52 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
53 Methylxanthine [EPC] 1 0.0000
54 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
55 Nitroimidazole Antimicrobial [EPC] 1 0.0000
56 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
57 Opioid Agonist [EPC] 4 0.0000
58 Mood Stabilizer [EPC] 3 0.0000
59 Non-Standardized Chemical Allergen [EPC] 1 0.0000
60 Anti-IgE [EPC] 1 0.0000
61 Amide Local Anesthetic [EPC] 1 0.0000
62 Central Nervous System Stimulant [EPC] 1 0.0000
63 Antiarrhythmic [EPC] 1 0.0000
64 Expectorant [EPC] 2 0.0000
65 Fluoroquinolone Antibacterial [EPC] 1 0.0000
66 Factor Xa Inhibitor [EPC] 2 0.0000
67 Osmotic Laxative [EPC] 2 0.0000
68 Calcium [EPC] 1 0.0000
69 Janus Kinase Inhibitor [EPC] 1 0.0000
70 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
71 Benzodiazepine [EPC] 4 0.0000
72 Thiazide Diuretic [EPC] 1 0.0000
73 Anti-epileptic Agent [EPC] 1 0.0000
74 Insulin Analog [EPC] 2 0.0000
75 beta-Adrenergic Blocker [EPC] 1 0.0000
76 Loop Diuretic [EPC] 1 0.0000
77 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
78 Platelet Aggregation Inhibitor [EPC] 1 0.0000
79 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000